Status:
UNKNOWN
Study of Pancreatic Neuroendocrine Tumors and Carcinomas in Alsace Region
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Pancreatic Neuroendocrine Tumor
Eligibility:
All Genders
18+ years
Brief Summary
Pancreatic Neuroendocrine tumors and carcinomas (pNET) see the last year their incidence and prevalence going up. On the basis of their grade of differentiation and proliferation ratio measured Ki67 s...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Major topic ((≥18 years)
- Subject with histologically confirmed pancreatic neuroendocrine tumor or carcinoma
- Subject with tumours or neuroendocrine carcinoma of the pancreas at any stage of the disease.
- Subject covered in one of the participating centres between 01/01/2008 and 01/01/2019
- Have a pre-therapeutic biological check-up
- Subject who has not expressed opposition to the use of his or her data for research purposes
- Exclusion criteria:
- Subject who expressed opposition to participate in the study
- Lack of histological data
- Minor subject
- Patient under the protection of justice
- Subject under guardianship or trusteeship
Exclusion
Key Trial Info
Start Date :
June 27 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2020
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT04134832
Start Date
June 27 2019
End Date
June 1 2020
Last Update
October 22 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service D'Hematologie Et D'Oncologie
Strasbourg, France, 67098